Jenny Rooke, Ph.D., is the founder and Managing Director of Genoa Ventures. She leverages her unique toolkit of genetics domain expertise, strategic business acumen, and venture investing to launch and empower the next generation of category-defying companies at the convergence of technology and biology. Dr. Rooke has nearly two decades of investing experience, beginning at Fidelity Biosciences in 2006 as a Kauffman Fellow. Coming off the annual JPMorgan Healthcare Conference in January, Dr. Rooke says she's encouraged by new scientific tools in development as well as the broader tailwinds for the biotech sector. She discusses her takeaways from the conference and the importance of emerging specialties in so-called “precision medicine” with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily.See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related